The xanthophyll carotenoid concentrated at the very centre of the macula, where it outnumbers lutein. Supplements supply dietary zeaxanthin, and some also contain meso-zeaxanthin, which the eye normally makes from lutein.
Zeaxanthin is almost always studied alongside lutein rather than separately, which makes its independent contribution difficult to assess. In AREDS2 it was given at 2 mg with 10 mg of lutein, so the trial supports the combination rather than either component. The interesting distinction is meso-zeaxanthin, an isomer that is not meaningfully present in food and is normally formed in the retina by conversion from lutein; supplements that add it are supplying something the eye usually makes for itself, on the argument that central macular pigment rises faster. Whether that translates into any visual or disease outcome has not been shown.
Sold as
Softgel, Capsule, Triple carotenoid formulas with lutein and meso-zeaxanthin
Standardised to
Milligrams; dietary RR-zeaxanthin and synthetic meso-zeaxanthin should be distinguished on the label and often are not — a product without this marker may not resemble what was studied.
Regulation: Sold as a dietary supplement in the US with no pre-market efficacy review. Meso-zeaxanthin is not a normal dietary constituent and has a shorter safety record than dietary zeaxanthin.
What the research used
The amounts, forms and durations published trials of Zeaxanthin actually administered.
These are the amounts published trials administered — not a recommendation, and not a dose to copy. Trial participants were screened, supervised and given a characterised preparation. What is in a retail bottle is frequently not what was studied, and the amount that suits one person is not general advice.
Studied for Age-related macular degeneration (AREDS2)
2 mg
Moderate
With 10 mg lutein, within the AREDS2 multi-nutrient formula · 5 years
Zeaxanthin was never tested alone in AREDS2. The result belongs to the combination and to the wider formula.
Studied for Macular pigment studies with meso-zeaxanthin
10–17 mg
Limited
Combined carotenoid formula, daily · 6–12 months
Doses in trials of triple-carotenoid formulas that raise central macular pigment faster than lutein alone. The endpoint is a pigment measurement, not vision or disease.
This is general information about food, not medical advice. It cannot diagnose, treat or replace guidance from a clinician who knows your history.
When it was taken
Each window says whether a trial compared it against an alternative, or whether it is convention and pharmacology. Most timing advice is the second kind.
Each timing below was actually compared against an alternative in a trial, which is unusual.
🍽️With food
Moderate
A fat-soluble carotenoid absorbed considerably better with a fat-containing meal, on the same measured basis as lutein.
Timing was tested. A trial compared this window against another and reported a difference.
The evidence in depth
Best supported: Moderate
What each association actually rests on, and the papers behind it. A rating describes the state of the research, not how promising the supplement sounds. How we rate evidence.
Zeaxanthin was part of the AREDS2 formulation associated with slower progression of intermediate macular degeneration, but it was never tested separately from lutein. The evidence supports the combination; the independent contribution of zeaxanthin is unknown.
Moderate evidence. Several human studies point the same way, with real caveats.
Trials of carotenoid formulas containing zeaxanthin report improved contrast sensitivity and glare recovery in some populations. The studies are small and it is difficult to separate zeaxanthin from lutein in any of them.
Limited evidence. Early human work, or mostly lab and animal research.
Deep research mode adds each paper’s own conclusion and stated limitations.
Things to know
Interactions, contraindications and dose limits, most serious first. Concentrated extracts interact with medication in ways the whole plant does not, so this section carries more weight here than it does on a food page.
Worth knowing
Never tested on its own
Every substantial trial gave zeaxanthin with lutein and usually inside a wider formula. A zeaxanthin-only product is being sold on evidence generated for a combination.
Worth knowing
Meso-zeaxanthin is not a dietary carotenoid
The eye normally produces meso-zeaxanthin from lutein. Supplying it directly is a newer intervention with a shorter safety record and no outcome evidence, whatever the macular pigment measurements show.
Too much
Skin tint at high intakes
As with other carotenoids, high intake can yellow the skin. It is cosmetic and fades once intake stops.
Worth knowing
The AREDS2 caveats apply
The evidence concerns people with existing intermediate macular degeneration taking a full multi-nutrient formula. It does not extend to healthy eyes or to zeaxanthin alone.
In the food catalogue
The whole-food form, where one exists. The evidence for a concentrated extract rarely transfers to the food, or the other way round — these are cross-links, not equivalents.